Auréa Group Invests in Zenagen and ACT/IV Haircare


The Body Shop owner plans to expand into premium haircare with its second haircare investment.

Beauty Packaging Staff01.09.25

Auréa Group has invested in Zenagen and ACT/IV haircare brands to boost its portfolio. This follows the Group’s acquisition of The Body Shop last year. Zenagen and ACT/IV are held by Nutraceutical Research Innovations, a U.S.-based holding company. 
 
Paul Raphael, Auréa’s co-founding partner, commented, 
 
“With increasing consumer demand for premium, purpose-driven haircare products, Nutraceutical Research Innovations is exceptionally well positioned to thrive. We look forward to bringing Auréa’s operational experience and unparalleled network in working with the team to unlock the brands’ next phase of growth.”
 
Founded in 2008, Zenagen is a professional haircare brand offering plant-based products that address hair thinning. 
 
Auréa hopes to strengthen Zenagen’s presence in the professional market while expanding into DTC platforms such as Amazon.
 
ACT/IV was founded in 2016 and has a strong presence in professional beauty channels. Auréa Group will prioritize ACT/IV’s digital growth and explore opportunities for further retail expansion.

Auréa has previously invested in hair growth brand Scandinavian Biolabs.


Read Next

The Body Shop Appoints a new CMO and CFO

Grabity Haircare by Polyphenol Factory Debuts at CES 2025

 



Source link

About The Author

Scroll to Top